Piramal Pharma

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue2,2162,7961,9922,1092,183
Expenses2,1672,5402,1102,1702,246
EBITDA349.87603.02165.10224.29238.97
EBIT170.11376.487.1336.24-4.62
Profit Before Tax66.80272.80-79.02-46.18-93.86
Net Profit3.68153.50-81.70-99.22-136.19
Financial Ratios
Operating Profit Margin16.65%22.48%10.57%11.70%9.73%
Net Profit Margin0.17%5.57%-4.83%-4.85%-5.40%
Earning Per Share (Diluted)0.031.16-0.62-0.75-1.03
Dividends Per Share0.000.000.000.000.00